Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

358
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
358
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Inhaled Medications01:23

Inhaled Medications

388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

201
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
201
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

385
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
385

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward development of soil-derived <i>Bacillus</i> isolates as lung cancer cytotoxic agents.

Biodesign research·2026
Same author

In Response to the Letter to the Editor: "Methodological Considerations in Interpreting Quality-of-Life Recovery in C19OD".

International forum of allergy & rhinology·2026
Same author

Recovery of Parosmia Preferentially Influences Longitudinal Improvement of Quality of Life in C19OD.

International forum of allergy & rhinology·2026
Same author

Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis.

International forum of allergy & rhinology·2026
Same author

Engineered probiotics for tumor-targeted combination chemoimmunotherapy.

bioRxiv : the preprint server for biology·2026
Same author

Interrelatedness of Neurocognitive Domain Functioning Between Unprompted and Prompted Identification Testing With Psychophysical Olfactory Evaluation in a Post-COVID-19 Cohort.

World journal of otorhinolaryngology - head and neck surgery·2026
Same journal

Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?

International forum of allergy & rhinology·2026
Same journal

A Comparison of Frailty Indices in Predicting Postoperative Outcomes After Endoscopic Sinus Surgery.

International forum of allergy & rhinology·2026
Same journal

North American Delphi Consensus Study on Sinonasal Malignancy Survivorship Care.

International forum of allergy & rhinology·2026
Same journal

Impact of Dysplasia on Inverted Papilloma Recurrence: A Systematic Review and Meta-Analysis.

International forum of allergy & rhinology·2026
Same journal

Inflammatory Signatures Beyond Th1/Th2 Endotypes Provide Insights Into Postoperative Recurrence in Chronic Rhinosinusitis.

International forum of allergy & rhinology·2026
Same journal

Characterizing the Scholarly Impact and Geographic Distribution of Rhinology Fellowship Graduates.

International forum of allergy & rhinology·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K

Engineered Microbial-Based Therapeutics Nose No Bounds: Extending Innovation to Rhinologic Disease Management.

Jonathan Pabón1,2,3, Tal Danino2,3,4, David A Gudis1

  • 1Department of Otolaryngology-Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

International Forum of Allergy & Rhinology
|August 18, 2025
PubMed
Summary
This summary is machine-generated.

Engineered bacteria offer a novel precision therapy for sinonasal diseases by modulating the nasal microbiome and immune response. This synthetic biology approach promises enhanced treatment for inflammatory conditions and malignancies.

Keywords:
engineered bacteriamicrobiomesynthetic biologytherapeutic delivery

More Related Videos

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

3.5K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

3.5K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.1K

Area of Science:

  • Synthetic biology
  • Microbiology
  • Rhinology

Background:

  • Sinonasal diseases present challenges for current therapeutic strategies.
  • The nasal mucosa harbors a complex microbial ecosystem with therapeutic potential.
  • Precision medicine approaches are needed for targeted sinonasal treatments.

Purpose of the Study:

  • To explore the application of engineered bacteria for treating sinonasal diseases.
  • To leverage synthetic biology for localized microbiota and immunomodulation.
  • To investigate novel therapeutic avenues for rhinologic conditions.

Main Methods:

  • Utilizing synthetic biology to engineer therapeutic bacteria.
  • Harnessing the native nasal microbiome for treatment strategies.
  • Developing microorganisms for targeted microbiota modulation.

Main Results:

  • Engineered bacteria show potential as a novel treatment modality.
  • Synthetic biology enables precise control over therapeutic microbial interventions.
  • The approach facilitates localized immunomodulation within the sinonasal environment.

Conclusions:

  • Engineered bacteria represent a promising, yet underexplored, therapeutic option for sinonasal diseases.
  • Synthetic biology offers innovative strategies for managing inflammatory processes and malignancies.
  • Harnessing the nasal microbiome can enhance treatment efficacy and open new management avenues.